NCT02047162

Impact of Bismuth Subsalicylate on Antimicrobial Use Among Adult Diarrhea Outpatients--Pakistan

Randomized, Double-blind, Placebo-controlled Trial of the Impact of Bismuth Subsalicylate on Antimicrobial Use Among Adult Diarrhea Outpatients in Pakistan

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 400 (actual)
• Sponsor: Centers for Disease Control and Prevention · Federal
• Sex: All
• Age: 15 Years – 65 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to learn whether bismuth subsalicylate can reduce use of antibiotics among adults with diarrhea in Pakistan.

Conditions

• Diarrhea

Interventions

Type	Name	Description
DRUG	Bismuth subsalicylate
OTHER	Placebo	Chewable tablets identical to intervention tablets, but missing the bismuth subsalicylate

Timeline

• Start date: 2014-05-01
• Primary completion: 2014-09-01
• Completion: 2014-09-01
• First posted: 2014-01-28
• Last updated: 2019-01-30

Locations

1 site across 1 country: Pakistan